| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/00015385.2017.1406884 |
| P698 | PubMed publication ID | 29179650 |
| P2093 | author name string | Tanica Lyngdoh | |
| Ashish Kumar Kakkar | |||
| Praloy Chakraborty | |||
| Rubina Mulchandani | |||
| P2860 | cites work | Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis | Q24679573 |
| Statins: Cholesterol guidelines and Indian perspective | Q26783226 | ||
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
| Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey | Q33972551 | ||
| SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group | Q34047278 | ||
| The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. | Q34276618 | ||
| Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization | Q34448710 | ||
| Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study | Q34490730 | ||
| Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment | Q34561428 | ||
| Statin use and musculoskeletal pain among adults with and without arthritis | Q35697228 | ||
| Medical lipid-regulating therapy: current evidence, ongoing trials and future developments | Q35782818 | ||
| Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology | Q35789818 | ||
| Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions | Q35915932 | ||
| Educational status-related disparities in awareness, treatment and control of cardiovascular risk factors in India | Q36801042 | ||
| Prevalence of musculoskeletal pain and statin use. | Q36841011 | ||
| Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series | Q37218787 | ||
| Management of statin intolerance | Q37414000 | ||
| Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). | Q37860655 | ||
| Statin dose in Asians: is pharmacogenetics relevant? | Q37951651 | ||
| Cardiovascular risk and events in 17 low-, middle-, and high-income countries | Q40218104 | ||
| Aiming at strategies for a complex problem of medical nonadherence. | Q41412254 | ||
| Doctor-patient communication in developing countries | Q42933702 | ||
| Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older. | Q43779477 | ||
| Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. | Q51334898 | ||
| Prevalence and risk factors of muscle complications secondary to statins | Q57312174 | ||
| Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin | Q57825140 | ||
| SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid | Q57825144 | ||
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2017-11-27 | |
| P1433 | published in | Acta Cardiologica | Q2491325 |
| P1476 | title | Statin related adverse effects and patient education: a study from resource limited settings |
Search more.